1214370-77-0

Basic information

• Product Name: 3-Amino-5-(trifluoromethyl)pyridine-2-carboxylic acid
• Synonyms: 3-Amino-5-(trifluoromethyl)pyridine-2-carboxylic acid;3-Amino-5-(trifluoromethyl)picolinic acid;2-Pyridinecarboxylic acid, 3-amino-5-(trifluoromethyl)-
• CAS NO: 1214370-77-0
• Molecular Formula: C7H5F3N2O2
• Molecular Weight: 206.1220096
• Mol File: 1214370-77-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 3-Amino-5-(trifluoromethyl)pyridine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-5-(trifluoromethyl)pyridine-2-carboxylic acid(1214370-77-0)
• EPA Substance Registry System: 3-Amino-5-(trifluoromethyl)pyridine-2-carboxylic acid(1214370-77-0)

Safety Data

• Hazardous Substances Data: 1214370-77-0(Hazardous Substances Data)

Usage

General Description

3-Amino-5-(trifluoromethyl)pyridine-2-carboxylic acid is a chemical compound that belongs to the pyridine carboxylic acids class. It is a derivative of pyridine and contains an amino group and a carboxylic acid group, as well as a trifluoromethyl substituent. 3-Amino-5-(trifluoromethyl)pyridine-2-carboxylic acid is used in the pharmaceutical industry as a building block for the synthesis of various drug molecules. It has potential applications in the development of new drugs for the treatment of various diseases, including cancer and inflammatory conditions. Additionally, its unique structure and properties make it a valuable tool for organic synthesis and medicinal chemistry research.

Upstream product

• 72587-15-6 2-chloro-3-nitro-5-(trifluoromethyl)pyridine 
• 1211515-30-8 3-amino-5-(trifluoromethyl)picolinonitrile 
• 1214336-90-9 3-amino-6-(2,6-difluorophenyl)-5-trifluoromethyl-2-pyridinecarboxylicacid 
• 866775-17-9 3-amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester 
• 866775-16-8 3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile 
• 33252-64-1 3-nitro-5-trifluoromethylpyridin-2-ol 

Relevant articles and documents

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel are established as the primary causative factor in the devastating lung disease cystic fibrosis (CF). More recently, cigarette smoke exposure has been shown to be asso

Pyridine and Pyrazine derivative for the Treatment of CF

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.